TickerFacts.

Company research / SCNI

Scinai Immunotherapeutics Ltd. (SCNI)

Build a valuation ↗↓ Download CSV

CIK 0001611747 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Scinai Immunotherapeutics Ltd. reported revenue of $1.31M. Revenue grew 99.2% from the prior annual period.

Key ratios (year ended 2025-12-31)

-202.3%
Gross margin
-575.3%
Operating margin
-633.6%
Net margin
-102.5%
Return on year-end equity
99.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-20

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue$1.31M$658.0Kn/an/an/a
Cost of Revenue$3.96M$1.24Mn/an/an/a
Gross Profit-$2.65M-$580.0Kn/an/an/a
R&D Expense$2.37M$5.53M$5.21M$5.76M$3.25M
Operating Income-$7.54M-$8.64M-$9.71M-$11.06M-$10.86M
Depreciation & Amortization$1.42M$1.65M$514.0K$562.0K$471.0K
EBITDA-$6.12M-$6.99M-$9.19M-$10.50M-$10.39M
Net Income-$8.31M$4.80M-$6.50M-$5.80M-$8.21M
EPS (Diluted)n/an/a$0.004$0.01-$0.02
Total Assets$11.63M$13.45M$17.47M$27.07M$32.04M
Shareholders' Equity$8.10M$9.98M-$4.57M-$1.76M$982.0K
Cash & Equivalents$1.66M$1.96M$4.87M$14.07M$17.37M
Operating Cash Flow-$6.03M-$6.33M-$9.38M-$7.26M-$7.43M
Capital Expenditures$24.0K$12.0K$637.0K$836.0K$139.0K
Free Cash Flow-$6.05M-$6.35M-$10.02M-$8.10M-$7.57M
Shares Outstanding13.87B3.41B1.86B989.29M739.05M
Weighted Average Diluted Shares9.34B3.23B1.56B754.08M564.58M
EPS (Basic)n/an/a$0.004$0.01-$0.02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView